Evidence map›Paper›PMID 38596830›Full record

ArticleAdvanced biology2024

Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro-Tumorigenic Macrophage Phenotypes.

Katherine H Griffin, Rachel R Mizenko, Vishalakshi Arun, Randy P Carney, J Kent Leach

Open access · hybridAbstract read
In one paragraph

Article in Advanced biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katherine H GriffinSchool of Veterinary Medicine, University of California, Davis, CA, 95616, USA.ORCID 0000-0003-1207-4624
Rachel R MizenkoDepartment of Biomedical Engineering, University of California, Davis, CA, 95616, USA.ORCID 0000-0002-9991-8799
Vishalakshi ArunDepartment of Biomedical Engineering, University of California, Davis, CA, 95616, USA.
Randy P CarneyDepartment of Biomedical Engineering, University of California, Davis, CA, 95616, USA.ORCID 0000-0001-8193-1664
J Kent LeachDepartment of Orthopaedic Surgery, UC Davis Health, Sacramento, CA, 95817, USA.ORCID 0000-0002-1673-3335
University of California, Davis · USUC Davis Health · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI KC KENT LLOYD · 2002 to 2026
$84.9M
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomesR01CA241666 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARNEY, RANDY · 2020 to 2024
$2.5M
Homogenized, engineered extracellular vesicles for intracranial targetingR01EB033389 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Randy Carney, Aijun Wang · 2023 to 2026
$2.4M
QE-HF-X Mass SpectrometerS10OD026918 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PHINNEY, BRETT S · 2020 to 2020
$600k
Engineered extracellular vesicles as a targeted drug delivery system for multiple sclerosisF31NS120590 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MIZENKO, RACHEL REGINA · 2022 to 2024
$109k
Foundation for the National Institutes of Health 1S10OD026918-01A1Foundation for the National Institutes of Health NCI P30CA093373Lawrence J. Ellison Endowed Chair of Musculoskeletal ResearchNCI NIH HHS P30 CA093373NCI NIH HHS R01 CA241666NIBIB NIH HHS R01 EB033389NIH HHS S10 OD026918NINDS NIH HHS F31 NS120590UC Davis Academic Senate Committee on Research GrantUC Davis School of Veterinary Medicine Endowment Funds
6 · The paper itself

Abstract

Metastasis is the principal factor in poor prognosis for individuals with osteosarcoma (OS). Understanding the events that lead to metastasis is critical to develop better interventions for this disease. Alveolar macrophages are potentially involved in priming the lung microenvironment for OS metastasis, yet the mechanisms involved in this process remain unclear. Since extracellular vesicles (EVs) are a known actor in primary tumor development, their potential role in OS metastagenesis through macrophage modulation is explored here. The interaction of EVs isolated from highly metastatic (K7M2) and less metastatic (K12) osteosarcoma cell lines is compared with a peritoneal macrophage cell line. An EV concentration that reproducibly induced macrophage migration is identified first, then used for later experiments. By confocal microscopy, both EV types associated with M0 or M1 macrophages; however, only K7M2-EVs are associated with M2 macrophages, an interaction that is abrogated by EV pre-treatment with anti-CD47 antibody. Interestingly, all interactions appeared to be surface binding, not internalized. In functional studies, K7M2-EVs polarized fewer macrophages to M1. Together, these data suggest that K7M2-EVs have unique interactions with macrophages that can contribute to the production of a higher proportion of pro-tumor type macrophages, thereby accelerating metastasis.

Indexed as

Bone NeoplasmsExtracellular VesiclesMacrophagesOsteosarcomaAnimalsCell Line, TumorCell MovementHumansMiceNeoplasm MetastasisPhenotypeTumor Microenvironmentcancerexosomesmacrophagemetastasisosteosarcoma

Identifiers

PMID38596830
PMCPMC11178448
OpenAlexW4394686116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.